Boston Scientific Corp. (BSX): Price and Financial Metrics

Boston Scientific Corp. (BSX): $49.08

0.48 (+0.99%)

POWR Rating

Component Grades














  • Growth is the dimension where BSX ranks best; there it ranks ahead of 88.35% of US stocks.
  • The strongest trend for BSX is in Quality, which has been heading up over the past 177 days.
  • BSX ranks lowest in Value; there it ranks in the 36th percentile.

BSX Stock Summary

  • BSX has a market capitalization of $69,185,096,615 -- more than approximately 96.98% of US stocks.
  • With a one year PEG ratio of 791.21, BOSTON SCIENTIFIC CORP is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 96.38% of US stocks.
  • BSX's current price/earnings ratio is 107.76, which is higher than 95.28% of US stocks with positive earnings.
  • If you're looking for stocks that are quantitatively similar to BOSTON SCIENTIFIC CORP, a group of peers worth examining would be ZTS, ABB, UBER, MSCI, and ALC.
  • BSX's SEC filings can be seen here. And to visit BOSTON SCIENTIFIC CORP's official web site, go to

BSX Valuation Summary

  • BSX's price/sales ratio is 5.5; this is 189.47% higher than that of the median Healthcare stock.
  • Over the past 243 months, BSX's price/sales ratio has gone down 0.4.

Below are key valuation metrics over time for BSX.

Stock Date P/S P/B P/E EV/EBIT
BSX 2023-03-24 5.5 3.9 107.8 47.9
BSX 2023-03-23 5.4 3.9 107.1 47.7
BSX 2023-03-22 5.4 3.9 107.4 47.8
BSX 2023-03-21 5.5 4.0 109.2 48.5
BSX 2023-03-20 5.5 4.0 109.1 48.5
BSX 2023-03-17 5.4 3.9 107.2 47.7

BSX Growth Metrics

    Its 5 year net income to common stockholders growth rate is now at 885.52%.
  • Its year over year cash and equivalents growth rate is now at -83.88%.
  • The year over year net income to common stockholders growth rate now stands at 275.12%.
Over the past 70 months, BSX's revenue has gone up $4.1e+09.

The table below shows BSX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 12,682 1,526 642
2022-09-30 12,567 1,197 597
2022-06-30 12,329 1,192 828
2022-03-31 12,162 1,528 754
2021-12-31 11,888 1,870 985
2021-09-30 11,470 2,065 1,100

BSX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BSX has a Quality Grade of C, ranking ahead of 73.14% of graded US stocks.
  • BSX's asset turnover comes in at 0.362 -- ranking 120th of 186 Medical Equipment stocks.
  • INGN, ECIA, and ATRC are the stocks whose asset turnover ratios are most correlated with BSX.

The table below shows BSX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.362 0.669 0.051
2021-03-31 0.328 0.649 0.032
2020-12-31 0.324 0.650 0.015
2020-09-30 0.331 0.672 0.003
2020-06-30 0.344 0.682 0.022
2020-03-31 0.386 0.704 0.043

BSX Price Target

For more insight on analysts targets of BSX, see our BSX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $51.08 Average Broker Recommendation 1.4 (Moderate Buy)

BSX Stock Price Chart Interactive Chart >

Price chart for BSX

BSX Price/Volume Stats

Current price $49.08 52-week high $49.46
Prev. close $48.60 52-week low $34.98
Day low $48.92 Volume 9,333,200
Day high $49.46 Avg. volume 7,675,033
50-day MA $47.22 Dividend yield N/A
200-day MA $42.98 Market Cap 70.54B

Boston Scientific Corp. (BSX) Company Bio

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiologyinterventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiologycardiac surgeryvascular surgeryendoscopyoncologyurology and gynecology. (Source:Wikipedia)

BSX Latest News Stream

Event/Time News Detail
Loading, please wait...

BSX Latest Social Stream

Loading social stream, please wait...

View Full BSX Social Stream

Latest BSX News From Around the Web

Below are the latest news stories about BOSTON SCIENTIFIC CORP that investors may wish to consider to help them evaluate BSX as an investment opportunity.

VREX or BSX: Which Is the Better Value Stock Right Now?

VREX vs. BSX: Which Stock Is the Better Value Option?

Yahoo | March 29, 2023

The Returns On Capital At Boston Scientific (NYSE:BSX) Don't Inspire Confidence

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Yahoo | March 29, 2023

Boston Scientific (NYSE:BSX) shareholders have earned a 12% CAGR over the last five years

When we invest, we're generally looking for stocks that outperform the market average. And in our experience, buying...

Yahoo | March 23, 2023

Boston Scientific's Wicked Rally Can Take the Stock 20% Higher

Boston Scientific made a new 52-week high on Tuesday. In the daily bar chart of BSX, below, I can see that share prices made a low back in June. The On-Balance-Volume (OBV) line shows a rise from October and tells me that traders are being more aggressive buyers of BSX.

Yahoo | March 21, 2023

Here's Why You Should Retain Boston Scientific (BSX) Now

Investors are optimistic about Boston Scientific (BSX), led by impressive value-added acquisitions.

Yahoo | March 20, 2023

Read More 'BSX' Stories Here

BSX Price Returns

1-mo 5.05%
3-mo 6.07%
6-mo 26.72%
1-year 9.80%
3-year 55.12%
5-year 79.65%
YTD 6.07%
2022 8.92%
2021 18.16%
2020 -20.50%
2019 27.96%
2018 42.56%

Continue Researching BSX

Want to see what other sources are saying about Boston Scientific Corp's financials and stock price? Try the links below:

Boston Scientific Corp (BSX) Stock Price | Nasdaq
Boston Scientific Corp (BSX) Stock Quote, History and News - Yahoo Finance
Boston Scientific Corp (BSX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9119 seconds.